SomaLogic boasts industry-leading reliability metrics that include sensitivity, specificity, and reproducibility.Ìý

The University of Colorado Connection

Professor Larry Gold (Â鶹Ãâ·Ñ°æÏÂÔØBoulder MCDB) founded SomaLogic, which pioneered the development of proteomics diagnostics and assays based on Gold’s SELEX technology. After going public in 2021, SomaLogic announced a merger with .

Funding Status and Investment Opportunities

  • Industry: Biotech​, Genomics, Health and Wellness​, Therapeutics, Diagnostics
  • Funding Stage: Exit
  • Contact for Investment Inquiries: Standard Bio Tools Inc. (LAB)

Venture Partners Programs​

Path to Commercialization


ÌýÌýThis page was last updated Sept. 3, 2024. Please contact us for corrections or updates